Is glargine (insulin glargine) available in generic form?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Glargine Is Available in Generic Form

Yes, insulin glargine is available in generic form. According to the 2023 and 2024 American Diabetes Association Standards of Care guidelines, there are multiple glargine biosimilar/follow-on products available on the market 1.

Evidence for Generic Insulin Glargine

The most recent evidence from the 2024 Standards of Care in Diabetes clearly shows:

  • Glargine biosimilar/follow-on products are available in:

    • U-100 prefilled pens (median AWP $190, range $74-$323)
    • U-100 vials (median AWP $118) 1
  • Generic prices are used when available for insulin glargine, with the U-100 vial and U-100 prefilled pen costing approximately $136 (AWP) and $109 (NADAC) 1

Cost Comparison

The availability of generic insulin glargine provides significant cost advantages compared to brand-name versions:

  • Generic glargine U-100 vial costs approximately $95-$118 (NADAC-AWP) 1
  • Brand-name glargine U-300 (higher concentration) costs significantly more at $290-$363 (NADAC-AWP) 1

Clinical Implications

The availability of generic insulin glargine has important implications for patient care:

  • Improved medication access and affordability for patients with diabetes
  • Similar clinical efficacy to brand-name versions
  • Long duration of action (up to 24 hours) with no pronounced peak 2
  • Can be administered once daily, typically at bedtime, though morning administration is also effective 2

Practical Considerations

When prescribing generic insulin glargine, consider:

  • Generic glargine maintains the same pharmacological properties as brand-name versions
  • It cannot be mixed with other insulin preparations in the same syringe 2
  • For patients requiring large insulin doses due to insulin resistance, two separate injections may be more effective 2
  • Supplemental rapid-acting insulin is still needed at mealtimes to control postprandial hyperglycemia 2

Pitfalls to Avoid

  • Don't confuse generic glargine with concentrated insulin glargine formulations (U-300), which are only available as brand-name products 1
  • Be aware that while generic glargine is available, other concentrated insulins (U-200, U-300, U-500) are typically only available as brand-name products
  • Remember that generic insulin glargine still requires proper storage and handling to maintain efficacy

The availability of generic insulin glargine represents an important advancement in making diabetes care more affordable while maintaining clinical efficacy for patients requiring basal insulin therapy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin Glargine: a review 8 years after its introduction.

Expert opinion on pharmacotherapy, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.